Stability of the HIV cascade of care throughout the COVID ‐19 pandemic in Europe: Results from the multinational EuroSIDA cohort study (2016–2022)
HIV Medicine · 2026-11 · 27 (11) · 1832-1844
DOI: 10.1111/hiv.70305 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift HIV Medicine, online erschienen am 29.09.2026. Verfasst von Olga Fursa und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Child & Adolescent Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK. Hauptthemen laut MEDLINE: HIV Infections, COVID-19. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: ViiV Healthcare, Janssen Scientific Affairs, Janssen R&D.
Abstract (Originalsprache)
Background
Prior to the COVID‐19 pandemic, antiretroviral therapy (ART) coverage and viral suppression were improving across Europe; however, the impact of the pandemic on HIV care remains uncertain.
Methods
In‐person visits, ART coverage and viral suppression among those on ART were described in the EuroSIDA cohort for each calendar year from 2016 to 2022 and compared across five European regions. Multivariable logistic regression was used to assess factors associated with having an in‐person visit and with viral suppression.
Results
Among 6740 participants, 71.9% were men, 34.9% were MSM, and the median age was 50 years (IQR: 42–56) at baseline (2016). The proportion of in‐person visits dropped from 75.0% in 2019 to 67.8% in 2020, increased to 74.5% in 2021 and was 72.3% in 2022. We observed a consistent increase in ART uptake over the years and a slight increase in missing HIV‐RNA data in 2020. The odds of attending clinic in person were lower in 2020 compared with 2016 (aOR: 0.81, 95% CI 0.75–0.87) but not in 2021 or 2022, while viral suppression increased over calendar time ( p < 0.0001). Compared to Central‐Western Europe, the other regions had lower odds of in‐person visits ( p < 0.0001, most prominently for Southern Europe, aOR: 0.18) and viral suppression ( p < 0.0001, most prominently for Eastern Europe, aOR: 0.07).
Conclusions
Our study confirmed the resilience of HIV care across Europe during the COVID‐19 pandemic, whereas the regional and country differences in clinic attendance and viral suppression highlighted the need to address persisting gaps in HIV care on a national level.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Child & Adolescent Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
- Centre of Excellence for Health, Immunity and Infections (CHIP), Rigshospitalet, Copenhagen, Denmark.
- Modena HIV Cohort, Università degli Studi di Modena, Modena, Italy.
- Infectious Diseases Observational Research Unit, Medical University of Warsaw, Warsaw, Poland.
- Infectious Diseases Service, Hospital Clínic-IDIBAPS, University of Barcelona, Barcelona, Spain.
- CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain.
ORCID-Profile: Olga Fursa, Wendy Bannister, Giovanni Guaraldi, Jose M Miro, Robert Zangerle, Katharina Kusejko, Pere Domingo, Thomas Benfield, Bartosz Szetela, Johannes Bogner, Marta Boffito
Förderung
- ViiV Healthcare
- Janssen Scientific Affairs
- Janssen R&D
- Bristol-Myers Squibb
- Merck Sharp & Dohme
- Gilead Sciences
- EU's Seventh Framework Programme for Research, Technological Development and Demonstration
- Danish National Research Foundation
Zitieren
APA
Fursa, O., Bannister, W., Guaraldi, G., Kowalska, J., Miro, J. M., Zangerle, R., Jilich, D., Viard, J. P., Kusejko, K., Nowak, P., Domingo, P., Mackintosh, C., Castagna, A., Benfield, T., Szetela, B., Bogner, J., Boffito, M., Peters, L., & EuroSIDA study group (2026). Stability of the HIV cascade of care throughout the COVID ‐19 pandemic in Europe: Results from the multinational EuroSIDA cohort study (2016–2022). HIV Medicine, 27(11), 1832-1844. https://doi.org/10.1111/hiv.70305
Vancouver
Fursa O, Bannister W, Guaraldi G, Kowalska J, Miro JM, Zangerle R, et al. Stability of the HIV cascade of care throughout the COVID ‐19 pandemic in Europe: Results from the multinational EuroSIDA cohort study (2016–2022). HIV Medicine. 2026;27(11):1832-1844. doi:10.1111/hiv.70305
BibTeX
@article{Fursa2026,
author = {Fursa, Olga and Bannister, Wendy and Guaraldi, Giovanni and Kowalska, Justyna and Miro, Jose M and Zangerle, Robert and Jilich, David and Viard, Jean-Paul and Kusejko, Katharina and Nowak, Piotr and Domingo, Pere and Mackintosh, Claire and Castagna, Antonella and Benfield, Thomas and Szetela, Bartosz and Bogner, Johannes and Boffito, Marta and Peters, Lars and EuroSIDA study group, EuroSIDA study group},
title = {Stability of the HIV cascade of care throughout the COVID ‐19 pandemic in Europe: Results from the multinational EuroSIDA cohort study (2016–2022)},
journal = {HIV Medicine},
year = {2026},
volume = {27},
number = {11},
pages = {1832--1844},
doi = {10.1111/hiv.70305}
}
EUVIMED